Financhill
Back

Evolent Health Quote, Financials, Valuation and Earnings

Sell
29

EVH
Evolent Health

Last Price:
23.08
Seasonality Move:
14.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Evolent Health Price Quote

$23.08
-0.01 (-0.86%)
(Updated: May 29, 2024 at 6:05 AM ET)

Evolent Health Key Stats

Sell
29
Evolent Health (EVH) is a Sell

Day range:
$22.96 - $23.61
52-week range:
$22.58 - $35.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.20
P/B ratio:
2.53%

Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-19.83%
Market cap:
$2.6B
Revenue:
$2B
EPS:
$-1.25

How Much Does Evolent Health Make?

Is Evolent Health Growing As A Company?

  • What Is Evolent Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.5%
  • What Is Evolent Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Evolent Health Stock Price Performance

  • Did Evolent Health Stock Go Up Last Month?
    Evolent Health share price went down by -16.49% last month
  • Did EVH's Share Price Rise Over The Last Year?
    EVH share price fell by -19.83% over the past 1 year

What Is Evolent Health 52-Week High & Low?

Evolent Health Price To Free Cash Flow

Is It Risky To Buy Evolent Health?

  • How Much Debt Does Evolent Health Have?
    Total long term debt quarterly is $597.9M
  • How Much Cash Does Evolent Health Have?
    Cash and short term investments quarterly total is $165.1M
  • What Is Evolent Health’s Book Value Per Share?
    Book value per share is 9.14

Is Evolent Health Cash Flow Positive?

  • What Is EVH Cash Flow From Operations?
    Cash flow from operations (TTM) is $155.5M
  • What Is Evolent Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$83.5M
  • What Is Evolent Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$30.3M

Evolent Health Return On Invested Capital

  • Is Management Doing A Good Job?
    EVH return on invested capital is -6.37%
  • What Is Evolent Health Return On Assets?
    ROA measures how assets are converting to revenues and is -4.17%
  • What Is EVH Return On Equity?
    ROE is a measure of profitability and is -9.86%

Evolent Health Earnings Date & Stock Price

Evolent Health Competitors

  • Who Are Evolent Health's Competitors?
    Below is a list of companies who compete with Evolent Health or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Cryo-Cell International Inc (CCEL)
    • Novo Integrated Sciences Inc (NVOS)
    • P3 Health Partners Inc (PIII)

Evolent Health Dividend Yield

Data Unavailable

Evolent Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.25%
Revenue: 49.56% 6.8%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 41.71
Upside from Last Price: 80.66%

Major Shareholders

  • How many EVH shares are owned by institutional investors?
    209.1M EVH shares are owned by institutional investors
  • How many EVH shares are owned by insiders?
    3.8M EVH shares are owned by insiders